Cargando…

Expression and clinical significance of undifferentiated embryonic cell transcription factor 1 in breast cancer

BACKGROUND: At present, due to the heterogeneity of breast cancer, common tumor markers have certain limitations in clinical prognostic evaluation. This suggests an unmet need for markers to predict clinical outcomes and potentially guide targeted therapies. The present study sought to explore the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Lou, Yuming, Jin, Shuxun, Hong, Xing, Hong, Zhongwu, Xu, Chaoyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906053/
https://www.ncbi.nlm.nih.gov/pubmed/36760370
http://dx.doi.org/10.21037/tcr-22-2890
_version_ 1784883932083257344
author Lou, Yuming
Jin, Shuxun
Hong, Xing
Hong, Zhongwu
Xu, Chaoyang
author_facet Lou, Yuming
Jin, Shuxun
Hong, Xing
Hong, Zhongwu
Xu, Chaoyang
author_sort Lou, Yuming
collection PubMed
description BACKGROUND: At present, due to the heterogeneity of breast cancer, common tumor markers have certain limitations in clinical prognostic evaluation. This suggests an unmet need for markers to predict clinical outcomes and potentially guide targeted therapies. The present study sought to explore the expression level and clinical significance of undifferentiated embryonic cell transcription factor 1 (UTF1) in breast cancer. METHODS: Immunohistochemistry (IHC) was used to detect the expression of UTF1 in 221 breast cancer samples. The clinical significance of UTF1 protein expression in breast cancer tissues was evaluated by combining clinicopathological parameters and UTF1 expression profile. We performed 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide (MTT) and clone formation assays to evaluate the effect of UTF1 on Bcap37 cell proliferation. Wound healing assay and transwell migration assay were used to evaluate the changes of cell invasion and migration ability, respectively. All experiments were performed with 3 biological replicates. Genomic differences after UTF1 overexpression were evaluated by RNA sequencing technology and the possible functions and regulatory mechanisms were elucidated. RESULTS: The findings showed that UTF1 expression level was significantly correlated with tumor size (P=0.004), but not with patient age, tumor histological stage, lymph node metastasis, as well as estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor-2 (HER-2), and Ki67 expression levels. Kaplan-Meier survival analysis and Cox proportional hazard model indicated that UTF1 expression was significantly associated with overall survival (OS) time of breast cancer patients. The median survival time of patients with high expression level of UTF1 was shorter compared with that of patients with low UTF1 expression level. The results of cell experiments showed that UTF1 overexpression could significantly promote the growth, proliferation, migration, and invasion of breast cancer cells. The RNA sequencing results showed that UTF1 was not only closely related to apoptosis genes, but also closely related to the nuclear factor (NF)-kappa B pathway. CONCLUSIONS: The findings of the current study indicate that UTF1 is involved in occurrence and tumor progression and is significantly associated with prognosis of breast cancer patients.
format Online
Article
Text
id pubmed-9906053
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-99060532023-02-08 Expression and clinical significance of undifferentiated embryonic cell transcription factor 1 in breast cancer Lou, Yuming Jin, Shuxun Hong, Xing Hong, Zhongwu Xu, Chaoyang Transl Cancer Res Original Article BACKGROUND: At present, due to the heterogeneity of breast cancer, common tumor markers have certain limitations in clinical prognostic evaluation. This suggests an unmet need for markers to predict clinical outcomes and potentially guide targeted therapies. The present study sought to explore the expression level and clinical significance of undifferentiated embryonic cell transcription factor 1 (UTF1) in breast cancer. METHODS: Immunohistochemistry (IHC) was used to detect the expression of UTF1 in 221 breast cancer samples. The clinical significance of UTF1 protein expression in breast cancer tissues was evaluated by combining clinicopathological parameters and UTF1 expression profile. We performed 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide (MTT) and clone formation assays to evaluate the effect of UTF1 on Bcap37 cell proliferation. Wound healing assay and transwell migration assay were used to evaluate the changes of cell invasion and migration ability, respectively. All experiments were performed with 3 biological replicates. Genomic differences after UTF1 overexpression were evaluated by RNA sequencing technology and the possible functions and regulatory mechanisms were elucidated. RESULTS: The findings showed that UTF1 expression level was significantly correlated with tumor size (P=0.004), but not with patient age, tumor histological stage, lymph node metastasis, as well as estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor-2 (HER-2), and Ki67 expression levels. Kaplan-Meier survival analysis and Cox proportional hazard model indicated that UTF1 expression was significantly associated with overall survival (OS) time of breast cancer patients. The median survival time of patients with high expression level of UTF1 was shorter compared with that of patients with low UTF1 expression level. The results of cell experiments showed that UTF1 overexpression could significantly promote the growth, proliferation, migration, and invasion of breast cancer cells. The RNA sequencing results showed that UTF1 was not only closely related to apoptosis genes, but also closely related to the nuclear factor (NF)-kappa B pathway. CONCLUSIONS: The findings of the current study indicate that UTF1 is involved in occurrence and tumor progression and is significantly associated with prognosis of breast cancer patients. AME Publishing Company 2023-01-13 2023-01-30 /pmc/articles/PMC9906053/ /pubmed/36760370 http://dx.doi.org/10.21037/tcr-22-2890 Text en 2023 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Lou, Yuming
Jin, Shuxun
Hong, Xing
Hong, Zhongwu
Xu, Chaoyang
Expression and clinical significance of undifferentiated embryonic cell transcription factor 1 in breast cancer
title Expression and clinical significance of undifferentiated embryonic cell transcription factor 1 in breast cancer
title_full Expression and clinical significance of undifferentiated embryonic cell transcription factor 1 in breast cancer
title_fullStr Expression and clinical significance of undifferentiated embryonic cell transcription factor 1 in breast cancer
title_full_unstemmed Expression and clinical significance of undifferentiated embryonic cell transcription factor 1 in breast cancer
title_short Expression and clinical significance of undifferentiated embryonic cell transcription factor 1 in breast cancer
title_sort expression and clinical significance of undifferentiated embryonic cell transcription factor 1 in breast cancer
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906053/
https://www.ncbi.nlm.nih.gov/pubmed/36760370
http://dx.doi.org/10.21037/tcr-22-2890
work_keys_str_mv AT louyuming expressionandclinicalsignificanceofundifferentiatedembryoniccelltranscriptionfactor1inbreastcancer
AT jinshuxun expressionandclinicalsignificanceofundifferentiatedembryoniccelltranscriptionfactor1inbreastcancer
AT hongxing expressionandclinicalsignificanceofundifferentiatedembryoniccelltranscriptionfactor1inbreastcancer
AT hongzhongwu expressionandclinicalsignificanceofundifferentiatedembryoniccelltranscriptionfactor1inbreastcancer
AT xuchaoyang expressionandclinicalsignificanceofundifferentiatedembryoniccelltranscriptionfactor1inbreastcancer